The legal action follows a series of disclosures that severely impacted the company’s market valuation. In June 2026, reports surfaced that the Brussels Public Prosecutor’s Office was investigating Wise’s European entity regarding suspicious transactions exceeding $582.5 million. Prosecutors cited potential links to corruption, fraud, and international drug trafficking. Following these reports, the company’s stock price dropped by nearly 10% over two consecutive trading days.
In section Releases
Wise Group plc Faces Securities Class Action Over Alleged Fraud
Investors who incurred losses holding Wise Group plc securities are facing a September 29, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation targets the company over allegations of securities fraud and systemic failures in its anti-money laundering compliance programs.
Regulatory scrutiny intensified on July 24, 2026, when U.S. officials denied the firm's application for a national trust bank license. Regulators explicitly pointed to deficiencies in Wise’s protocols for combating money laundering and terrorism financing. This disclosure triggered a further 6.2% decline in share price, closing at $11.33. Investors seeking to participate in the Pomerantz LLP class action may contact Danielle Peyton to review their eligibility and the specific allegations regarding breaches of fiduciary duty.
Comments (0)
No comments yet. Be the first!